glp 1 and thyroid medication The Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care GLP-1 medications can be powerful

doi: 10.3389/fmicb.2021.689958 163 MathipaMGThantshaMS

B9 (Folate) : Needed for cell growth, amino acid metabolism, the formation of red and white blood cells and proper cell division

Cellular and Molecular Mechanisms of Fibrosis

Pande, M

Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2